{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910787332603321"]
[null,null,"Titolo",null,"Horizons in clinical nanomedicine / / edited by Varvara Karagkiozaki, Stergios Logothetidis"]
[null,null,"Pubbl/distr/stampa",null,"Boca Raton, FL : , : CRC Press : , : Pan Stanford Publishing, , [2014]"]
[{"$nulls":4},"©2014"]
[null,null,"ISBN",null,"0-429-07371-2"]
[{"$nulls":4},"981-4411-56-6"]
[null,null,"Descrizione fisica",null,"1 online resource (364 p.)"]
[null,null,"Disciplina",null,"610.28"]
[null,null,"Soggetti",null,"Nanomedicine"]
[{"$nulls":4},"Nanostructured materials - Toxicology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Front Cover; Contents; Preface; Chapter 1: Introduction in Clinical Nanomedicine; Chapter 2: Nanomedicine Combats Atherosclerosis; Chapter 3: Nanomedicine Advancements in Cancer Diagnosis and Treatment; Chapter 4: Nanomedicine and Blood Diseases; Chapter 5: Nanomedicine and Orthopaedics; Chapter 6: Nanopharmaceutics: Structural Design of Cationic Gemini Surfactant-Phospholipid-DNA Nanoparticles for Gene Delivery; Chapter 7: Nanomedicine and Embryology: Causative Embryotoxic Agents Which Can Pass the Placenta Barrier and Induce Birth Defects; Chapter 8: Nanomedicine and HIV/AIDS"]
[{"$nulls":4},"Chapter 9: Nanoscaffolds and Other Nano-Architectures for Tissue Engineering-Related ApplicationsChapter 10: Biocompatible 2D and 3D Polymeric Scaffolds for Medical Devices; Chapter 11: Regenerative Dentistry: Stem Cells Meet Nanotechnology; Chapter 12: Toxicity and Genotoxicity of Metal and Metal Oxide Nanomaterials: A General Introduction; Chapter 13: Analogies in the Adverse Immune Effects of Wear Particles, Environmental Particles, and Medicinal Nanoparticles"]
[null,null,null,"Sommario/riassunto","Nanomedicine-the application of nanotechnology to health sciences-has the potential to address many important medical problems by exploiting the advanced physicochemical characteristics of nanostructured materials and devices. It can revolutionize conventional medicine by offering cutting-edge developments in the processes of diagnosing, treating, and preventing diseases, injuries, or genetic "]
[{"$nulls":4},"disorders. Thus, clinical nanomedicine holds promise to preserve and improve human health.This book provides a comprehensive overview on the forefront developments of nanotechnology in various domains of"]